Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing

1 Dec 2016

Abstract excerpt

BACKGROUND: The implementation of liquid biopsy for biomarker testing and response to treatment monitoring in cancer patients would presumable increase laboratory throughput, requiring the development of automated methods for circulating free DNA (cfDNA) isolation. METHODS: RSC (MR) ccfDNA Plasma Kit and the later with QIAamp Circulating Nucleid Acid (QCNA) Kit using 57 plasma samples from cancer patients. cfDNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28149760
DOI: 10.21037/tlcr.2016.12.03

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testingPMID 28149760Read ↗

A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.Semantic proximity Read ↗

Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer PatientsSemantic proximity Read ↗

Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoringSemantic proximity Read ↗

Genomics and Epigenomics Approaches for the Quantification of Circulating Tumor DNA in Liquid Biopsy: Relevance of a Multimodal StrategySemantic proximity Read ↗

Optimization of Sources of Circulating Cell-Free DNA Variability for Downstream Molecular Analysis.Semantic proximity Read ↗

Circulating free DNA in the era of precision oncology: Pre‐ and post‐analytical concernsSemantic proximity Read ↗

Circulating Cell-Free DNA Yield and Circulating-Tumor DNA Quantity from Liquid Biopsies of 12 139 Cancer Patients.Semantic proximity Read ↗

Bioinformatics Analysis for Circulating Cell-Free DNA in CancerSemantic proximity Read ↗

Comparative analysis of nuclear and mitochondrial DNA from tissue and liquid biopsies of colorectal cancer patientsSemantic proximity Read ↗

Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation ProtocolSemantic proximity Read ↗

Cell-free DNA as a biomarker in cancerSemantic proximity Read ↗

Direct circulating tumor DNA detection from unpurified plasma using a digital PCR platform.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.